GT101 Injection for the Treatment of Metastatic or Recurrent Solid Tumors
Clinical trial NCT05430373 · RECRUITING
Trial details
- NCT number
- NCT05430373
- Sponsor
- Grit Biotechnology
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-05-23
- Primary completion
- 2025-09-25
- Enrollment
- 31
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.